open access

Vol 7, No 6 (2006): Practical Diabetology
Original articles (submitted)
Published online: 2006-10-18
Get Citation

The evaluation of the central retina after laser therapy in diabetic retinopathy

Marta Misiuk-Hojło, Aneta Hill-Bator, Piotr Marszalik, Maria Magnowska-Woźniak
Diabetologia Praktyczna 2006;7(6):390-395.

open access

Vol 7, No 6 (2006): Practical Diabetology
Original articles (submitted)
Published online: 2006-10-18

Abstract

INTRODUCTION. The purpose of this study is the evaluation of the photocoagulation impact on central retina in diabetic retinopathy.
MATERIAL AND METHODS. 101 patients (200 eyes), age varied from 23 to 72 years, 47 women and 54 men with insulin-dependent and insulin non-dependent diabetes were analyzed. On the basis of detailed ophthalmology and angiography examination diabetic maculopathy were found in 168 eyes. The focal macular edema was stated in 105 eyes (62.5%), diffuse maculopathy in 54 eyes (32.1%) and ischemic maculopathy in 9 eyes (5.4%). Patients were treated with argon laser Coherent 920, in accordance with DRS and ETDRS recommendations. The effects of laser therapy were estimated in 1.2 to 4.4 years after photocoagulation.
RESULTS. In 88,6% eyes with focal macular edema and in 83.3% eyes with diffuse maculopathy we noticed an improvement after the photocoagulation. Stabilization was found in 8.6% eyes with focal macular edema and in 11.1% eyes with diffuse maculopathy. Deterioration was found in 2.8% eyes with focal maculopathy and in 5.6% eyes with diffuse maculopathy. Ischemic maculopathy was stabilized in 60%, improved only in 20%. The amount of microvessels decreased in 81.8% eyes, the amount of hard exudates in 77%, intraretinal blood extravasations in 24.2% eyes and zones of lack of perfusion only in 3.6%.
CONCLUSION. The positive results of photocoagulation, especially in focal and diffuse maculopathy, justify the application of laser treatment as a method of choice in diabetic retinopathy.

Abstract

INTRODUCTION. The purpose of this study is the evaluation of the photocoagulation impact on central retina in diabetic retinopathy.
MATERIAL AND METHODS. 101 patients (200 eyes), age varied from 23 to 72 years, 47 women and 54 men with insulin-dependent and insulin non-dependent diabetes were analyzed. On the basis of detailed ophthalmology and angiography examination diabetic maculopathy were found in 168 eyes. The focal macular edema was stated in 105 eyes (62.5%), diffuse maculopathy in 54 eyes (32.1%) and ischemic maculopathy in 9 eyes (5.4%). Patients were treated with argon laser Coherent 920, in accordance with DRS and ETDRS recommendations. The effects of laser therapy were estimated in 1.2 to 4.4 years after photocoagulation.
RESULTS. In 88,6% eyes with focal macular edema and in 83.3% eyes with diffuse maculopathy we noticed an improvement after the photocoagulation. Stabilization was found in 8.6% eyes with focal macular edema and in 11.1% eyes with diffuse maculopathy. Deterioration was found in 2.8% eyes with focal maculopathy and in 5.6% eyes with diffuse maculopathy. Ischemic maculopathy was stabilized in 60%, improved only in 20%. The amount of microvessels decreased in 81.8% eyes, the amount of hard exudates in 77%, intraretinal blood extravasations in 24.2% eyes and zones of lack of perfusion only in 3.6%.
CONCLUSION. The positive results of photocoagulation, especially in focal and diffuse maculopathy, justify the application of laser treatment as a method of choice in diabetic retinopathy.
Get Citation

Keywords

diabetic retinopathy; laser photocoagulation; diabetic maculopathy

About this article
Title

The evaluation of the central retina after laser therapy in diabetic retinopathy

Journal

Clinical Diabetology

Issue

Vol 7, No 6 (2006): Practical Diabetology

Pages

390-395

Published online

2006-10-18

Bibliographic record

Diabetologia Praktyczna 2006;7(6):390-395.

Keywords

diabetic retinopathy
laser photocoagulation
diabetic maculopathy

Authors

Marta Misiuk-Hojło
Aneta Hill-Bator
Piotr Marszalik
Maria Magnowska-Woźniak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl